Results 221 to 230 of about 72,133 (313)

The evolution of robotic cystectomy [PDF]

BJU International, 2014
openaire   +2 more sources

A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study. [PDF]

In Vivo
Gambale E, Giorgione R, Basso U, Galli L, Fornarini G, Atzori F, Scagliarini S, Masini C, Baldazzi V, Scolari F, Mela MM, Maruzzo M, Vascotto IA, Rossi V, Rossini D, Roviello G, Lavacchi D, Serni S, Minervini A, Pillozzi S, Antonuzzo L.   +20 more
europepmc   +1 more source

Evaluating the Long-Term Utility and Cost-Effectiveness of Computed Tomography (CT) Surveillance Beyond Five Years After Radical Cystectomy: A 10-Year Follow-Up Study. [PDF]

Cureus
Elsandoby O, Akroush R, Roodhouse A, Kusuma VRM, Perry M.   +4 more
europepmc   +1 more source

Effect of Pembrolizumab on Lymph Node Dissection in Patients Who Experienced Bladder Cancer Recurrence Following Radical Cystectomy [PDF]

Yoshihiko Tasaki, Takashi Nagai, Taku Naiki, Yusuke Noda, Rena Okawa, Masaru Tomita, Yosuke Sugiyama, Yoshihisa Mimura, Kazuki Odagiri, Naoki Ito, Yuji Hotta, Nobuhiko Shimizu, Toshiki Etani, Shuzo Hamamoto, Atsushi Okada, Yoko Furukawa‐Hibi, Takahiro Yasui   +16 more
openalex   +1 more source

Transition to robotic surgery in urologic oncology: a comparative analysis between pre-robotic and robotic eras in a high-volume tertiary center. [PDF]

J Robot Surg
Porreca A, Di Gianfrancesco L, De Marchi D, Simonetti F, Coppola M, Stefano A, Gallina P, Amodeo A, Franzoso G, Giuriola A, Bello SD, Marino F.   +11 more
europepmc   +1 more source

Testosterone replacement therapy and bladder cancer. [PDF]

Can Urol Assoc J
Kanaan MF, Breau RH, Lavallée LT, McIsaac DI, Witherspoon L.   +4 more
europepmc   +1 more source

Open versus robot-assisted radical cystectomy: 30-day perioperative comparison and predictors for complication, readmission, and cost-to-patient charges

, 2019
Jason F. Flamiatos
openalex   +1 more source

Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer. [PDF]

J Urol
Chang SS, Chamie K, Kramolowsky E, Gonzalgo ML, Agarwal PK, Bassett JC, Bjurlin M, Cher ML, Clark W, Cowan BE, David R, Goldfischer E, Guru K, Jalkut MW, Kaffenberger SD, Kaminetsky J, Corcoran A, Koo AS, Sexton WJ, Tikhonenkov SN, Shah MS, Trabulsi EJ, Trainer AF, Spilman P, Huang M, Bhar P, Drusbosky LM, Sender L, Brown B, Reddy S, Soon-Shiong P.   +30 more
europepmc   +1 more source

Local and Systemic Effects of Chronic Intracavernous Injection of Papaverine, Prostaglandine E1 and Saline in Primates [PDF]

, 1989
Aboseif, Sherif R., Bosch, Ruud J. L. H., Breza, J., Bénard, Francois, Lue, Tom F., Stackl, W., Stief, Christian Georg, Tanagho, Emil A.   +7 more
core  

Clinical outcomes of neobladder or augmentation after cystectomy in locally advanced colorectal cancer involving urinary tract: case series. [PDF]

BMC Urol
Lee C, Nam W, Kim CW, Yoon YS, You D.
europepmc   +1 more source